Dr. Howard Dobson Joins Endpoint to Enhance Radiology and Imaging Capabilities

March 31, 2025

With four decades of experience in veterinary radiology and imaging-based research, Dr. Howard Dobson brings exceptional skills in data analysis, experimental design, and detailed report generation to enhance preclinical studies. His expertise in diagnostic imaging and interventional techniques delivers clinically relevant outcomes for complex research programs.

Endpoint Preclinical proudly welcomes Dr. Howard Dobson, BVM&S, DVSc, Dip. ACVR, to our Expert Network. A highly respected veterinary radiologist, Dr. Dobson has dedicated over 40 years to imaging-based research across various preclinical models. His extensive background in both academic and CRO settings has earned him recognition for accurate image interpretation and sophisticated analytical capabilities. View Howard’s Profile

Dr. Dobson manages the entire imaging process, from acquiring diagnostic images to producing clear, regulatory-compliant reports. He combines deep knowledge of imaging modalities with thoughtful study design to ensure the reproducibility and quality of data. His innovative approach has allowed him to address complex anatomical challenges effectively, enhancing imaging methodologies and reliability.

One of his key contributions includes the development of a fluoroscopy-guided intrathecal injection technique, significantly improving the accuracy of test article delivery and distribution analysis. This advancement exemplifies his commitment to developing imaging methods that generate meaningful insights.

Throughout his career, Dr. Dobson has consistently emphasized precision, efficiency, and collaborative teamwork. His previous roles include serving as Service Chief of Radiology at the Ontario Veterinary College’s Veterinary Teaching Hospital, leading imaging research at InterVivo Solutions (now Transpharmation), and providing expert consulting to numerous organizations. His comprehensive experience in study design, ethics, and regulatory compliance makes him a trusted advisor in preclinical research.

For me, preclinical research hinges on data integrity and clarity. My goal is to help teams effectively navigate imaging complexities, from protocol development and data collection to rigorous analysis and reporting. Each project benefits from clear, precise outcomes. — Howard Dobson

At Endpoint Preclinical, Dr. Dobson will focus on enhancing imaging protocols, optimizing study designs, and supporting clients with data analysis and reporting. His proficiency with imaging software like Radiant, 3D Slicer, and VivoQuant—combined with his expertise in fluoroscopy-guided techniques—uniquely positions him to address complex imaging challenges with precision and clarity.

Dr. Dobson’s work will support diverse applications in preclinical research, including intrathecal drug administration, brain atlas development, and addressing challenging anatomical regions in various models. His strategic insight combined with technical proficiency strengthens the Endpoint team.

We are excited to welcome Dr. Dobson to Endpoint Preclinical, confident that his extensive knowledge will significantly advance our imaging capabilities. To learn how Dr. Dobson’s skills can support your preclinical studies, contact us today.